Stay updated on Pembrolizumab for Desmoplastic Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Desmoplastic Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab for Desmoplastic Melanoma Clinical Trial page
- Check5 days agoChange DetectedTwo dates (2026-04-01 and 2026-03-31) were added and two dates (2026-03-24 and 2026-03-21) were removed from the Study Record Dates.SummaryDifference0.0%

- Check13 days agoChange DetectedRevision log updated to v3.5.0 with new timestamps (2026-03-21 and 2026-03-24), replacing the previous v3.4.3.SummaryDifference0.1%

- Check20 days agoChange DetectedStudy record dates show additions on 2026-03-14 and 2026-03-17, and deletions on 2026-03-07 and 2026-03-10.SummaryDifference0.0%

- Check27 days agoChange DetectedThe Publications section was updated to replace the online-ahead-of-print Nat Cancer citation with the finalized Nat Cancer article (SWOG S1512 cohort A) and update its bibliographic details. The update also notes the 2026-03-10 entry date and revision to v3.4.3.SummaryDifference0.1%

- Check49 days agoChange DetectedMinor version update from v3.4.1 to v3.4.2; no changes to study details, eligibility, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check56 days agoChange DetectedMinor site-wide updates were made (revision v3.4.1 added and the funding-status notice removed), with no impact on study content or user tasks. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Desmoplastic Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Desmoplastic Melanoma Clinical Trial page.